View More View Less
  • 1 Internal Cardiology Department, University Hospital and Masaryk University, Brno, Czech Republic
  • | 2 Institute of Biostatistics and Analysis, Masaryk University, Brno, Czech Republic
  • | 3 Internal Cardiology Department, University Hospital, Jihlavská 20, 625 00, Brno, Czech Republic
Restricted access

Abstract

Atrial fibrillation (AF) is a supraventricular tachyarrhythmia characterized by uncoordinated atrial activation with consequence deterioration of atrial mechanical function. It has an incidence of approximately 6 million people in European Union as a result of the aging population and affects about 1 percent of patients younger than 60 years and about 8 percent of patients older than 80 years [2, 10]. AF is also the most common supraventricular arrhythmia in patients with acute myocardial infarction (MI) and/or acute heart failure (AHF), complicating its course with an incidence between 6–21% in hospitalized patients with MI although recent advances in pharmacological treatment of myocardial infarction has probably changed the impact of this arrhythmia and vice versa. These two diseases (AF + MI) are a growing health concern all over the world and when one considers the occurrence of these two diseases simultaneously, the relevance of AF in the course of MI and vice versa cannot be overemphasized in cardiovascular health care and more importantly its treatment and prevention. Aim: This article therefore aims to correlate data from controlled studies to summarize the incidence of AF in MI and vice versa and the impact of pharmacotherapy. Data from our registry Brno (3502 patients with MI and/or AHF) show that AF is not a predictor of short-term mortality in patients with myocardial infarction and/or heart failure, but is a strong predictor of long-term mortality.

  • 1. Amiodarone Trials Meta-Analysis Investigators 1997 Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomized trials Lancet 350 1417 1424.

    • Search Google Scholar
    • Export Citation
  • 2. A.J. Camm P. Kirchhof G.Y.H. Lip et al. 2010 Guidelines for the management of atrial fibrillation Eur Heart J 31 2369 2429.

  • 3. S. Connolly J. Pogue R. Hart et al. 2006 Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): A randomised controlled trial Lancet 367 1903 1912.

    • Search Google Scholar
    • Export Citation
  • 4. S.J. Conolly M.D. Ezekowitz D. Phil et al. 2009 Dabigatran versus warfarin in patients with atrial fibrillation NEJM 361 1139 1151.

  • 5. K. Dickstein A. Cohen-Solal G. Fillipatos 2008 The Task Force on Heart Failure of the European Society of Cariology: The ESC Guidelines on Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 Eur Heart J 10 933 989.

    • Search Google Scholar
    • Export Citation
  • 6. G. Mancia S. Laurent L. Agabiti-Rosei et al. 2009 Reappraisal of European guidelines on hypertension management: a European Society of hypertension Task Force document Journal of Hypertension 27 2121 2158.

    • Search Google Scholar
    • Export Citation
  • 7. J. McMurray A. Cohen-Solal R. Dietz et al. 2005 Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: putting guidelines into practice Eur J Heart Fail 7 710 721.

    • Search Google Scholar
    • Export Citation
  • 8. W.Y. Robert et al. 2010 Population trends in the incidence and outcomes of acute myocardial infarction N Engl J Med 362 2155 2165.

  • 9. J. Schmitt G. Duray B.J. Gersh S.H. Hohnloser 2009 Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications Eur Heart J 30 1038 1045.

    • Search Google Scholar
    • Export Citation
  • 10. S. Stewart C.L. Hart et al. 2001 Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study Heart 86 516 521.

    • Search Google Scholar
    • Export Citation
  • 11. The Capricorn Investigators: Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet 357, 13851390 (2001).

    • Search Google Scholar
    • Export Citation
  • 12. The Stroke Prevention in Atrial Fibrillation Investigators 1992 Predictors in thromboembolism in atrial fibrillation. I Clinical features of patients at risk Ann Intern Medicine 116 1 5.

    • Search Google Scholar
    • Export Citation
  • 13. B.K. William J.B. Emelia 2008 Status of the Epidemiology of Atrial Fibrillation Med Clin N Am 92 17 14.

  • 14. P.J. Zimetbaum et al. 2000 Incidence and predictors of myocardial infarction among patients with atrial fibrillation J Am Coll Cardiol 36 1223 1227.

    • Search Google Scholar
    • Export Citation

2019  
Scimago
H-index
11
Scimago
Journal Rank
0,220
Scimago
Quartile Score
Medicine (miscellaneous) Q3
Scopus
Cite Score
155/133=1,2
Scopus
Cite Score Rank
General Medicine 199/529 (Q2)
Scopus
SNIP
0,343
Scopus
Cites
206
Scopus
Documents
23

 

Interventional Medicine and Applied Science
Language English
Size  
Year of
Foundation
2009
Publication
Programme
changed title
Volumes
per Year
 
Issues
per Year
 
Founder Akadémiai Kiadó
Founder's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 2061-1617 (Print)
ISSN 2061-5094 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Feb 2021 0 0 0
Mar 2021 0 0 0
Apr 2021 0 0 0
May 2021 3 0 0
Jun 2021 1 0 0
Jul 2021 0 0 0
Aug 2021 0 0 0